Perioperative cardiac arrhythmias

British Journal of Anaesthesia

Volumn 93, Issue 1, 2004, Pages 86-94

  Thompson, A ^a   Balser, Jeff R ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Complications, arrhythmia; Heart, arrhytmia

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ATENOLOL; ATROPINE; BRETYLIUM; CALCIUM CHANNEL; CALCIUM ION; DILTIAZEM; DOFETILIDE; DROPERIDOL; ESMOLOL; IBUTILIDE; ISOPRENALINE; LIDOCAINE; MAGNESIUM SULFATE; MEXILETINE; PHENYTOIN; PLACEBO; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM ION; PROCAINAMIDE; PROPRANOLOL; QUINIDINE; SODIUM CHANNEL; SODIUM ION; SOTALOL; TOCAINIDE; VERAPAMIL;

ARTIFICIAL HEART PACEMAKER; CARDIOVERSION; DEFIBRILLATOR; DRUG TARGETING; HEART ARRHYTHMIA; HEART AUTOMATICITY; HEART SUPRAVENTRICULAR ARRHYTHMIA; HUMAN; MEDICAL DECISION MAKING; MORBIDITY; MORTALITY; PERIOPERATIVE PERIOD; PEROPERATIVE COMPLICATION; PRIORITY JOURNAL; REENTRY ARRHYTHMIA; REVIEW; SURVIVAL; TORSADE DES POINTES;

EID: 3242787268     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/aeh166     Document Type: Article

References (57)

1. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. The Sicilian gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Circulation 1991; 84: 1831-51
2. The American Heart Association, in collaboration with the International Liaison Committee on Resuscitation. Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 6: advanced cardiovascular life support: 7D: the tachycardia algorithms. Circulation 2000; 102: 1158-65
3. Abbott GW, Sesti F, Splawski I, et al. MiRPI forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 1999; 97: 175-87
4. Abedin Z, Soares J, Phillips DF, Sheldon WC. Ventricular tachyarrhythmias following surgery for myocardial revascularization. Chest 1977; 72: 426-8
5. Belardinelli L, Isenberg G. Isolated atrial myoctes: adenosine and acetylcholine increase potassium conductance. Am J Physiol 1983; 244: H737-47
6. Bigger JT, Jr. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators [see comments]. N Engl J Med 1997; 337: 1569-75
7. Chew C, Hecht H, Colett J, McCallister R, Singh B. Influence of severity of ventricular dysfunction on hemodynamic responses to intravenously administered verapamil in ischemic heart disease. Am J Cardiol 1981; 47: 927-32
8. Cohn JN, Bristow MR, Chien KR, et al. Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research. Circulation 1997; 95: 766-70
9. Das G, Ferris J. Esmolol in the treatment of supraventricular tachyarrhythmias. Can J Cardiol 1988; 4: 177-80
10. DelleKarth G, Geppert A, Neunteufl T, et al. Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias. Crit Care Med 2001; 29: 1149-53
11. Dorian P, Cass D, Schwartz B, Cooper R, Gelaznikas R, Barr A. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J Med 2002; 346: 884-90
12. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery - Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Anesth Analg 2002; 94: 1052-64
13. Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. N Engl J Med 1991; 324: 781-8
14. Elami A, Merin G, Flugelman MY, et al. Usefulness of late potentials on the immediate postoperative signal-averaged electrocardiogram in predicting ventricular tachyarrhythmias early after isolated coronary artery bypass grafting. Am J Cardiol 1994; 74: 33-7
15. El-Sherif N. Polymorphic ventricular tachycardia. In: Podrid PJ, Kowey PR, eds. Cardiac Arrhythmia: Mechanisms, Diagnosis, and Management. Baltimore: Williams and Wilkins, 1995; 936-50
16. Engelstein ED, Lippman N, Stein KM, Lerman BB. Mechanism-specific effects of adenosine on atrial tachycardia. Circulation 1994; 89: 2645-54
17. England MR, Gordon G, Salem M, Chernow B. Magnesium administration and dysrhythmias after cardiac surgery. JAMA 1992; 268: 2395-402
18. Galve E, Rius T, Ballester R, et al. Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study. J Am Coll Cardiol 1996; 27: 1079-82
19. Gorgels APM, van den Dool A, Hofs A, et al. Comparison of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia. Am J Cardiol 1996; 78: 43-6
20. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 2002; 106: 2145-61
21. Henzi I, Sonderegger J, Tramer MR. Efficacy, dose-response, and adverse effects of droperidol for prevention of postoperative nausea and vomiting. Can J Anaesth 2000; 47: 537-51
22. Hill RP, Lubarsky DA, Phillips-Bute B, et al. Cost-effectiveness of prophylactic antiemetic therapy with ondansetron, droperidol, or placebo. Anesthesiology 2000; 92: 958-67
23. Installe E, Schoevaerdts JC, Gadisseux P, Charles S, Tremouroux J. Intravenous amiodarone in the treatment of various arrhythmias following cardiac operations. J Thorac Cardiovasc Surg 1981; 81: 302-8
24. Kao LW, Kirk MA, Evers SJ, Rosenfeld SH. Droperidol, QT prolongation, and sudden death: what is the evidence? Ann Emerg Med 2003; 41: 546-58
25. Kaul TK, Fields BL, Riggins LS, Wyatt DA, Jones CR. Ventricular arrhythmia following successful myocardial revascularization: incidence, predictors and prevention. Eur J Cardiothorac Surg 1998; 13: 629-36
26. King FG, Addetia AM, Peters SD, Peachey GO. Prophylactic liclocaine for postoperative coronary artery bypass patients, a double-blind, randomized trial. Can J Anaesth 1990; 37: 363-8
27. Kochiaclakis GE, Igoumenidis NE, Solomou MC, Kaleboubas MD, Chlouverakis GI, Vardas PE. Efficacy of amiodarone for the termination of persistent atrial fibrillation. Am J Cardiol 1999; 83: 58-61
28. Kron I, DiMarco J, Harman P, et al. Unanticipated postoperative ventricular arrhythmias. Ann Thorac Surg 1984; 38: 317-22
29. Kuchar DL, Thorburn CW, Sammel NL. Prediction of serious arrhythmic events after myocardial infarction: signal-averaged electrocardiogram, Holter monitoring, and radionuclide ventriculography. J Am Coll Cardiol 1987; 9: 531-8
30. Kudenchuk PJ, Cobb LA, Copass MK, et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med 1999; 341: 871-8
31. Liebold A, Wahba A, Birnbaum DE. Low-energy cardioversion with epicardial wire electrodes: new treatment of atrial fibrillation after open heart surgery. Circulation 1998; 98: 883-6
32. Lukas A, Antzelevitch C. Differences in the electrophysiological response of canine ventricular epicardium and endocardium to ischemia: role of the transient outward current. Circulation 1993; 88: 2903-15
33. Mandel WJ. Sustained monomorphic ventricular tachycardia. In: Podrid FJ, Kowey PR, eds. Cardiac Arrhythmia: Mechanisms, Diagnosis, and Management Baltimore: Williams and Wilkins, 1995; 919-35
34. Mason JW, Investigators ftE. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. N Engl J Med 1993; 329: 452-8
35. Mattioni TA, Zheutlin TA, Dunnington C, Kehoe RF. The proarrhythmic effects of amiodarone. Prog Cardiovasc Dis 1989; 31: 439-46
36. Michel PL, Mandagout O, Vahanian A, et al. Ventricular arrhythmias in aortic valve disease before and after aortic valve replacement. Acta Cardiol 1992; 47: 145-56
37. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996; 335: 1933-40
38. Myerburg RJ. Sudden cardiac death: exploring the limits of our knowledge. J Cardiovasc Electrophysiol 2001; 12: 369-81
39. O'Kelly B, Browner WS, Massie B, Tubau J, Ngo L, Mangano DT. Ventricular arrhythmias in patients undergoing noncardiac surgery. JAMA 1992; 268: 217-21
40. Perry JC, Knilans TK, Marlow D, Denfield SW, Fenrich AL, Friedman RA. Intravenous amiodarone for life-threatening tachyarrhythmias in children and young adults. J Am Coll Cardiol 1993; 22: 95-8
41. Priori SG, Barhanin J, Hauer RN, et al. Genetic and molecular basis of cardiac arrhythmias: impact on clinical management parts I and II. Circulation 1999; 99: 518-28
42. Priori SG, Diehl L, Schwartz PJ. Torsade de Pointes. In: Podrid PJ, Kowey PR, eds. Cardiac Arrhythmia: Mechanisms, Diagnosis, and Management. Baltimore: Williams and Wilkins, 1995; 951-63
43. Roden DM. Antiarrhythmic drugs. In: JG Hardman LL, ed. Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th Edn. New York: McGraw-Hill, 1996; 839-74
44. Roden DM. Taking the 'idio' out of 'idiosyncratic': predicting torsades de pointes [editorial]. Pacing Clin Electrophysiol 1998; 21: 1029-34
45. Roden DM, Woosley RL, Primm K. Incidence of clinical features of the quinidine associated long QT syndrome. Implications for patient care. Am Heart J 1986; 111: 1088-93
46. Rowland E, McKenna WJ, Gulker H, Krikler DM. The comparative effects of diltiazem and verapamil on atrioventricular conduction and atrioventricular reentry tachycardia. Circ Res 1983; 52: 163-8
47. Kr potassium channel. Cell 1995; 81: 299-307
48. Santinga JT, Kirsh MM, Flora JD, Brymer JF. Factors relating to late sudden death in patients having aortic valve replacement. Ann Thorac Surg 1980; 29: 249-53
49. Singh SN, Fletcher RD, Fisher SG, et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 1995; 333: 77-82
50. Smith RC, Leung JM, Keith FM, Merrick S, Mangano DT. Ventricular dysrhythmias in patients undergoing coronary artery bypass graft surgery: incidence, characteristics, and prognostic importance. Am Heart J 1992; 123: 73-81
51. Stambler BS, Wood MA, Ellenbogen KA, et al. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Circulation 1996; 94: 1613-21
52. Tang J, Watcha MF, White PF. A comparison of costs and efficacy of ondansetron and droperidol as prophylactic antiemetic therapy for elective outpatient gynecologic procedures. Anesth Analg 1996; 83: 304-13
53. Tisdale JE, Padhi ID, Goldberg AD, et al. A randomized, double-blind comparison of intravenous diltiazem and digoxin for atrial fibrillation after coronary artery bypass surgery. Am Heart J 1998; 135: 739-47
54. Topol EJ, Lerman BB, Baughman KL, Platia EV, Griffith LSC. De novo refractory ventricular tachyarrhythmias after coronary revascularization. Am J Cardiol 1986; 57: 57-9
55. Vaughan Williams EM. A classification of antiarrhythmic actions reassessed after a decade of new drugs. J Clin Pharmacol 1984; 24: 129-47
56. Waldo AL, Henthorn RW, Epstein AE, Plumb VJ. Diagnosis and treatment of arrhythmias during and following open heart surgery. Med Clin North Am 1984; 68: 1153-70
57. Walsh RW, Porter CB, Starling MR, O'Rourke RA. Beneficial hemodynamic effects of intravenous and oral diltiazem in severe congestive heart failure. J Am Coll Cardiol 1984; 3: 1044-50